Cargando…

Refining anti‐inflammatory therapy strategies for bronchopulmonary dysplasia

Bronchopulmonary dysplasia (BPD) is a severe lung disease of preterm infants, which is characterized by fewer, enlarged alveoli and increased inflammation. BPD has grave consequences for affected infants, but no effective and safe therapy exists. We previously showed that prophylactic treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudloff, Ina, Cho, Steven X., Bui, Christine B., McLean, Catriona, Veldman, Alex, Berger, Philip J., Nold, Marcel F., Nold‐Petry, Claudia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431131/ https://www.ncbi.nlm.nih.gov/pubmed/27957795 http://dx.doi.org/10.1111/jcmm.13044

Ejemplares similares

Remifentanil ameliorates intestinal ischemia-reperfusion injury
por: Cho, Steven SC, et al.
Publicado: (2013)

Protein C preserves microcirculation in a model of neonatal septic shock
por: Fischer, Doris, et al.
Publicado: (2009)

The immunological landscape in necrotising enterocolitis
por: Cho, Steven X., et al.
Publicado: (2016)

Circulating Interleukin-37 Levels in Healthy Adult Humans – Establishing a Reference Range
por: Santarelli, Danielle M., et al.
Publicado: (2021)

Thrombosis in the critically ill neonate: incidence, diagnosis, and management
por: Veldman, Alex, et al.
Publicado: (2008)

Parsing the IL-37-Mediated Suppression of Inflammasome Function
por: Rudloff, Ina, et al.
Publicado: (2020)

Failure of Interferon γ to Induce the Anti-Inflammatory Interleukin 18 Binding Protein in Familial Hemophagocytosis
por: Nold-Petry, Claudia A., et al.
Publicado: (2010)

Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension
por: Bui, Christine B., et al.
Publicado: (2019)

The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation
por: Owen, Josephine C., et al.
Publicado: (2023)

Interleukin 37 is a fundamental inhibitor of innate immunity
por: Nold, Marcel F, et al.
Publicado: (2010)

Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities
por: Cho, Steven X., et al.
Publicado: (2020)

The Role of the Interleukin-1 Family in Complications of Prematurity
por: Green, Elys A., et al.
Publicado: (2023)

Timing of the First Dose of the Hepatitis B Vaccine in Preterm Infants
por: Lei, Donna, et al.
Publicado: (2022)

The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function
por: Prentice, Ralley E., et al.
Publicado: (2023)

Interleukin-1: an important target for perinatal neuroprotection?
por: Kelly, Sharmony B., et al.
Publicado: (2022)

IL-37 increases in patients after ischemic stroke and protects from inflammatory brain injury, motor impairment and lung infection in mice
por: Zhang, Shenpeng R., et al.
Publicado: (2019)

Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus
por: Godsell, Jack, et al.
Publicado: (2016)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Anakinra Pilot – a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants
por: Green, Elys A., et al.
Publicado: (2022)

Persistent Inflammation in Cerebral Palsy: Pathogenic Mediator or Comorbidity? A Scoping Review
por: Paton, Madison C. B., et al.
Publicado: (2022)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Gp96 Peptide Antagonist gp96-II Confers Therapeutic Effects in Murine Intestinal Inflammation
por: Nold-Petry, Claudia A., et al.
Publicado: (2017)

Bronchopulmonary Dysplasia: Endothelial Cells in the Driver’s Seat
por: Vohwinkel, Christine U., et al.
Publicado: (2021)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Untersuchung der Reaktion $e^{+}e^{-} \to \mu^{+}\mu^{-}$-beim OPAL Experiment
por: Nold, F
Publicado: (1992)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
por: Kurahara, David, et al.
Publicado: (2014)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Hospital management of severe bronchopulmonary dysplasia
por: Moretti, Corrado, et al.
Publicado: (2015)

Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia
por: Podraza, Wojciech, et al.
Publicado: (2018)

The rate and pattern of bronchopulmonary dysplasia in Kuwait
por: Al-Essa, Mazen, et al.
Publicado: (2004)

Impact of bronchopulmonary dysplasia on brain and retina
por: Poon, Annie Wing Hoi, et al.
Publicado: (2016)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

New Pharmacologic Approaches to Bronchopulmonary Dysplasia
por: Roberts, Katelyn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v7btrk6ug2tuuall7dfgaieobo